Listed by the USPTO as RODRIGUEZ, RAYNA B
Tech Center 1600 • Art Units: 1628 1692
This examiner grants 33% of resolved cases
RODRIGUEZ, RAYNA B is assigned to Technology Center 1600 and art unit 1628. The profile includes 593 resolved cases, a 33.2% allowance rate, and a median of 1,269 days to allowance. The allowance rate indicates that prosecution outcomes in the measured record are more often unresolved in favor of allowance than allowed, while the timing points to a lengthy prosecution cycle.
The interview lift is 19.0%, making interviews a relevant strategic consideration even though the overall allowance rate is limited. Genentech Inc., Janssen Pharmaceutica NV, and Deciphera Pharmaceuticals LLC are recorded companies. The listed firms are COOLEY LLP, BakerHostetler, and Sheppard, Mullin, Richter & Hampton LLP, providing useful context for applicant and counsel activity in the art unit.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18785844 | CDK INHIBITORS | Non-Final OA | Genentech, Inc. |
| 18544236 | METHODS OF TREATING CANCER USING B-RAF INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS | Final Rejection | Genentech, Inc. |
| 18009682 | CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS | Final Rejection | AMGEN INC. |
| 17599252 | OSMOTIC PRESSURE REGULATOR FOR PERITONEAL DIALYSATE CONTAINING D-ALLOSE AND/OR D-ALLULOSE | Final Rejection | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY |
| 18293475 | ANTISEPTIC COMPOSITION | Final Rejection | OTSUKA PHARMACEUTICAL FACTORY, INC. |
| 17916504 | NOVEL FORMUATIONS | Final Rejection | ARECOR LIMITED |
| 18285136 | CRYSTALLINE FORM OF PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF | Final Rejection | SUNSHINE LAKE PHARMA CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy33.2% of resolved applications examined by Rayna B Rodriguez were allowed (593 resolved cases), compared with 25.9% across Art Unit 1628 over the last five years.
This examiner's interview lift is +19.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Rayna B Rodriguez took 1,269 days on average from filing to allowance.
Rayna B Rodriguez examines applications in Art Unit 1628 in Tech Center 1600 (Biotechnology & Pharmaceuticals).